SKU: CTLT Category:


This is our first report on healthcare tech solutions provider, Catalent Inc. The company’s first quarter of fiscal year 2024 earnings call highlighted a solid start to the fiscal year despite turbulence in several markets. The management noted improved focus on cash flow, citing benefits from better working capital management and increased analytical rigor around capital expenditure spending. Catalent is expected to finalize fiscal 2023 and first quarter 2024 SEC filings later in the month, and there’s an ongoing focus on achieving company goals through strategic planning and operations. The company is currently evaluating various strategies and operational changes aimed at maximizing long-term value for shareholders.

Our Report Structure:

⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures

Want unlimited access to our reports? Purchase our $99 annual subscription!